Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-10

Clinical Trial Update: Medtronic Evolut™ EXPAND TAVR I Feasibility Study [NA]

View source ↗

Summary

Clinical feasibility study for Medtronic Evolut EXPAND TAVR I was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Evolut EXPAND TAVR I

Snippet

Sponsor: Medtronic Cardiovascular | Conditions: Aortic Valve Stenosis | NA | Status: TERMINATED | Results posted: 2024-01-10